Spectrum of rare splenic lesions

---

Case Report

Author Details : Sushma Nigudgi, Sneha Sheelwanth, Anita. A.M, Anuradha Patil, Sainath .K Andola

Volume : 3, Issue : 3, Year : 2018

Article Page : 223-227

https://doi.org/10.18231/2581-3706.2018.0046

Suggest article by email

Get Permission

---

Abstract

Introduction: The human spleen is the largest component of the reticuloendothelial system, having unique anatomic and functional importance. Spleen has been considered as mysterious organ with World population incidence of focal splenic lesions ranging from 0.103 to 0.20%.
Aims and Objective: The aim of the present study was to study the pathological spectrum of rare lesions of spleen.
Materials and Methods: The present study was conducted in the department of Pathology in a tertiary care centre, over a period of three years from Aug 2014 to July 2017.
Results: Total 10 rare cases of splenic lesions were studied. Out of which eight were splenectomies and two were from fetal autopsies. Primary lesions were 9 and secondary lesion was 1. We found one case each of hemangiomatosis of spleen, small B cell lymphoma of spleen, Sickling of spleen, hydatid cyst of spleen, traumatic spleen avulsion, metastasis to spleen from lung and two case were of asplenia with right isomerism and situsambigus and two cases were of extra lymphatic filariasis of spleen.
Conclusion: Morphological changes in splenic lesions are less discussed due to fewer number of splenectomy cases. We hereby analyzed rare splenic lesions which has contributed to the knowledge of splenic pathology.

Keywords: Pathological spectrum, Splenic lesions, Splenectomy.

How to cite : Nigudgi S, Sheelwanth S, A.m A, Patil A, Andola S ., Spectrum of rare splenic lesions. IP J Diagn Pathol Oncol 2018;3(3):223-227

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.